Prophylactic efficacy of phenytoin, acetazolamide and hydrochlorothiazide in horses with hyperkalaemic periodic paralysis.
Horses with hyperkalaemic periodic paralysis were challenged with an oral dose of potassium chloride, and the prophylactic efficacy of phenytoin, acetazolamide and hydrochlorothiazide was evaluated, with at least three weeks separating the trials of each drug. After the administration of potassium chloride without prophylactic medication the horses' clinical signs ranged from generalised fine muscle fasciculations to gross tremors, and weakness with occassional prolapse of the nictitating membrane; plasma potassium concentration increased significantly (P < 0.01) from 4.0 +/- 0.2 to 6.0 +/- 1.01 mmol litre-1. After treatment with acetazolamide the administration of potassium chloride resulted in a significant (P < 0.02) increase in plasma potassium from 3.7 +/- 0.3 to 4.5 +/- 0.4 mmol litre-1 and two of five horses showed clinical signs unless the dosage was increased from 2.2 to 4.4 mg kg-1 twice daily. Three of the four horses treated with hydrochlorothiazide showed clinical signs but their plasma potassium did not rise significantly (3.6 +/- 0.3 to 4.6 +/- 1.0 mmol litre-1). None of the five horses treated with phenytoin showed clinical signs despite a significant increase in plasma potassium from 3.8 +/- 0.6 to 5.3 +/- 1.1 mmol litre-1 (P < 0.05). In general the clinical signs were not correlated consistently with the plasma levels of potassium, and phenytoin appeared to prevent the clinical signs in spite of the hyperkalaemia.
Beech
J
J
Department of Clinical Studies, University of Pennsylvania, School of Veterinary Medicine, Kennett Square 19348, USA.
Lindborg
S
S
D000086:Acetazolamide / Q000627:therapeutic use*; D000818:Animals; D004232:Diuretics / Q000627:therapeutic use*; D006734:Horse Diseases; D006736:Horses; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006947:Hyperkalemia / Q000150:complications / Q000517:prevention & control / Q000662:veterinary*; D008297:Male; D009919:Orchiectomy; D010243:Paralysis / Q000209:etiology / Q000517:prevention & control / Q000662:veterinary*; D010672:Phenytoin / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood
D004232:Diuretics; D006852:Hydrochlorothiazide; D010672:Phenytoin; D000086:Acetazolamide; D011188:Potassium